10-Q: TerrAscend Q2 Loss Widens Amid Michigan Exit, Debt Refinancing

TerrAscend Corp. reported a widened net loss in Q2 2025, primarily due to an impairment charge from exiting the Michigan market, while also completing a significant debt refinancing and an Ohio acquisition.

Summary

• Net loss widened to $48.1 million for the three months ended June 30, 2025, compared to $6.2 million in the prior year period.
• Net loss for the six months ended June 30, 2025, was $60.4 million, up from $21.1 million for the same period in 2024.
• Revenue from continuing operations decreased by 3% to $65.0 million in Q2 2025 and 5% to $129.3 million for the six months ended June 30, 2025.
• Discontinued operations, primarily related to the exit from the Michigan market, resulted in a $41.7 million loss in Q2 2025, including a $34.9 million impairment charge.
• Gross profit margin from continuing operations improved to 51.1% in Q2 2025 (from 49.6% in Q2 2024) and 52.5% for the six months (from 49.5% in Q2 2024).
• Adjusted EBITDA from continuing operations was $16.0 million for Q2 2025 and $34.2 million for the six months.
• Completed the acquisition of certain assets of Ratio Cannabis, an Ohio dispensary, for a total consideration of $10.1 million.
• Approved a plan to exit the Michigan market, expecting to reduce the workforce by approximately 21% (252 employees) by the end of Q4 2025.
• Subsequent to quarter-end, completed a $79.0 million upsize to the existing FG Loan, using $68.0 million to retire the Pelorus Term Loan and other indebtedness.
• Signed an option agreement to acquire Union Chill Cannabis Company LLC, a New Jersey dispensary, for $13.0 million.

Sentiment

Score: 3

Explanation: The significant net loss and impairment charge from the Michigan exit, coupled with a decline in continuing operations revenue, indicate poor short-term financial performance. While strategic restructuring and debt refinancing are positive for long-term stability, the immediate impact is negative.

Positives

• Gross profit margin from continuing operations improved to 51.1% in Q2 2025 from 49.6% in Q2 2024, and to 52.5% for the six months from 49.5% in the prior year.
• Successfully refinanced and upsized the FG Loan by $79.0 million post-quarter, using $68.0 million to retire higher-interest debt, improving the debt structure.
• Acquired Ratio Cannabis, an Ohio dispensary, for $10.1 million, expanding operational footprint in a key market.
• Signed an option agreement to acquire Union Chill Cannabis Company LLC, a New Jersey dispensary, for $13.0 million, indicating strategic growth in established markets.
• General and administrative expenses decreased by 7% in Q2 2025 and 4% for the six months, driven by reductions in professional fees and stock-based compensation.
• Market share growth in Maryland, supported by cultivation projects, led to an increase of $1.8 million in wholesale revenue for Q2 2025.
• Retail revenue increased by $1.2 million due to acquisitive growth and $1.2 million from strong consumer demand in emerging markets for Q2 2025.

Negatives

• Net loss significantly widened to $48.1 million in Q2 2025 from $6.2 million in Q2 2024, and to $60.4 million for the six months from $21.1 million in the prior year.
• Revenue from continuing operations decreased by 3% in Q2 2025 to $65.0 million and 5% for the six months to $129.3 million, primarily due to a decline in wholesale revenue and reduced foot traffic/average order sizes in retail.
• Discontinued operations in Michigan resulted in a substantial $41.7 million loss in Q2 2025 and $46.3 million for the six months, including a $34.9 million impairment charge on assets.
• The Michigan exit plan involves a workforce reduction of approximately 21% (252 employees) by Q4 2025, incurring $1.05 million to $1.2 million in employee transition costs.
• Net cash provided by operating activities decreased by $15.3 million to $10.8 million for the six months ended June 30, 2025, compared to $26.1 million in the prior year.
• Net cash used in investing activities increased by $6.3 million to $11.1 million for the six months, primarily due to the Ratio Cannabis acquisition.
• Provision for income taxes increased by 20% to $20.1 million for the six months, primarily due to accrued interest and penalties.
• The company's stock option repricing on June 24, 2025, resulted in an incremental expense of $868 thousand.

Risks

• The use of cannabis remains illegal under U.S. federal law, despite state-level legalization, posing ongoing regulatory and enforcement risks.
• Uncertainty exists around the timing of any legislative changes impacting unfavorable tax treatment, such as Section 280E of the Code, which significantly affects profitability.
• The company may not be able to realize the cost savings and benefits initially anticipated from the Michigan exit, and actual costs may be greater than expected.
• Increased competition in the Michigan market contributed to the impairment charge and negatively impacted gross margins in discontinued operations.
• The company is subject to financial covenants on its loans payable, and future financial results below required levels could lead to non-compliance.
• The ability to generate cash flows from operations and obtain necessary financing on acceptable terms is an ongoing assumption for forward-looking statements.
• The cannabis industry involves inherent risks and uncertainties that are subject to change based on various factors.
• Potential actions by individuals or U.S. federal government enforcement actions against the company could materially impact operations.
• The company's ability to source investment opportunities, complete future acquisitions, and finance such acquisitions is subject to market conditions and capital availability.
• The company's ability to market itself to the capital markets and raise equity is influenced by its corporate ownership structure.
• The company is involved in lawsuits incidental to its business, including litigation related to intellectual property, product liability, employment, and commercial matters.

Future Outlook

The company expects the sale of Michigan assets to be substantially completed in the second half of 2025, leading to an overall workforce reduction of approximately 21% by the end of Q4 2025. Upon full implementation, the Michigan exit plan is expected to result in reduced annual run-rate expenses by more than $200 million by the end of fiscal year 2025. The company also anticipates funding future capital requirements through cash from operations, market offerings, additional debt, and asset sales. It intends to meet its capital commitments and assess corrective initiatives if financial results fall below debt covenant requirements.

Management Comments

• Management believes that any ultimate liability from legal proceedings would not have a material adverse effect on the Consolidated Balance Sheets or Consolidated Statements of Operations and Comprehensive Loss.
• Management believes that the provision for income taxes based on the actual effective tax rate for the quarter is the best estimate for the annual effective tax rate.
• Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.
• The Chief Operating Decision Maker (CODM) regularly evaluates the performance of the single reportable segment using gross profit margin as its closest measure to GAAP.
• The company expects that G&A expenses will increase in absolute dollars as the business grows.
• The company intends to meet its capital commitments through cash from ongoing operations, market offerings, additional debt from additional creditors, sale of real property, sale leaseback transactions, and exercise of options and warrants.

Industry Context

The cannabis industry continues to face challenges, particularly in the U.S., where federal illegality persists despite state-level legalization. This creates complex regulatory and tax environments, such as Section 280E, which significantly impacts profitability. The Michigan market, specifically, is experiencing increased competition and price compression, leading to strategic exits by some operators like TerrAscend. Companies are adapting by consolidating operations into more profitable markets and optimizing debt structures, as evidenced by TerrAscend's recent refinancing and acquisitions in Ohio and New Jersey, which are emerging or established adult-use markets.

Comparison to Industry Standards

• NA

Management Changes

Corporate Governance

Legal Proceedings

• The company is involved in a number of lawsuits incidental to its business, including litigation related to intellectual property, product liability, employment, and commercial matters.
• As of June 30, 2025, there were no pending lawsuits that could reasonably be expected to have a material effect on the results of the company's Consolidated Financial Statements.

Related Party Transactions

• Certain funds controlled by Jason Wild, the company's Executive Chairman, held $5.5 million of the total loan principal balance of the FG Loan as of June 30, 2025.
• Subsequent to June 30, 2025, certain funds controlled by Jason Wild invested approximately $1.6 million under the FG Loan Amendment.
• The stock option repricing on June 24, 2025, included insiders of the company, which was approved by shareholders at the Annual General Meeting.

Stakeholder Impact

• Shareholders: Experienced significant net loss and impairment, but also strategic restructuring and debt optimization aimed at long-term value. Share repurchases are ongoing, and stock option repricing could impact dilution.
• Employees: Approximately 21% of the workforce (252 employees) is expected to be reduced by Q4 2025 due to the Michigan market exit, incurring $1.05 million to $1.2 million in transition costs.
• Creditors: Debt refinancing and upsizing of the FG Loan, along with the retirement of other indebtedness, impacts the company's debt structure and repayment schedule, potentially improving financial stability.
• Customers: The exit from the Michigan market will impact customers in that state, while acquisitions in Ohio and New Jersey aim to expand customer reach in other key markets.
• Suppliers: Changes in operational footprint due to market exits and acquisitions may lead to adjustments in supplier relationships and procurement needs.

Next Steps

• Substantially complete the sale of Michigan assets in the second half of 2025.
• Implement workforce reduction of approximately 21% by the end of Q4 2025.
• Complete the acquisition of Union Chill Cannabis Company LLC, subject to customary closing conditions and regulatory approvals.
• Continue to assess and undertake appropriate corrective initiatives to comply with debt covenants if financial results are below required levels.
• Potentially draw further from the $35.0 million uncommitted term loan facility.
• Continue to evaluate uncertain tax positions and monitor routine IRS examinations.

Key Dates

Recommendation

The company is undergoing a significant strategic restructuring by exiting the unprofitable Michigan market, which, while causing a substantial one-time impairment charge and widened net loss in the short term, is expected to improve long-term profitability and reduce annual run-rate expenses by over $200 million. The successful debt refinancing and upsizing of the FG Loan also strengthen the balance sheet by retiring higher-interest debt. However, the decline in continuing operations revenue and the large net loss indicate ongoing challenges. The stock option repricing and management changes add a layer of uncertainty. Given the current transitional phase with both significant negatives and strategic positives, a 'hold' recommendation is appropriate as investors await clearer signs of improved performance from the streamlined operations and new acquisitions.

Keywords

Cannabis, Marijuana, SEC Filing, 10-Q, Financial Results, TerrAscend, Michigan Exit, Debt Refinancing, Acquisition, Dispensary, Cultivation, Wholesale Revenue, Retail Revenue, Impairment Charge, Adjusted EBITDA, Share Repurchase, Corporate Governance, Risk Factors, Financial Reporting